- Research article
- Open Access
- Open Peer Review
This article has Open Peer Review reports available.
No MERS-CoV but positive influenza viruses in returning Hajj pilgrims, China, 2013–2015
- Xuezheng Ma†1,
- Fang Liu†2,
- Lijuan Liu1,
- Liping Zhang1,
- Mingzhu Lu2,
- Abuduzhayier Abudukadeer3,
- Lingbing Wang3,
- Feng Tian3,
- Wei Zhen4,
- Pengfei Yang5 and
- Kongxin Hu1Email author
© The Author(s). 2017
Received: 19 September 2016
Accepted: 4 October 2017
Published: 10 November 2017
There is global health concern that the mass movement of pilgrims to and from Mecca annually could contribute to the international spread of Middle East Respiratory Syndrome Coronavirus (MERS-CoV). In China, about 11,000 Muslim pilgrims participate in the Hajj gathering in Mecca annually. This is the first report of MERS-CoV and respiratory virus molecular screening of returning pilgrims at points of entry in China from 2013 to 2015.
Methods and results
A total of 847 returning Hajj pilgrims participated in this study. The test results indicated that of the travelers, 34 tested positive for influenza A virus, 14 for influenza B virus, 4 for metapneumo virus, 2 for respiratory syncytial virus, and 3 for human coronavirus. There was a significant difference in the rates of positive and negative influenza virus tests between Hajj pilgrims with symptoms and those without. The detection rates of influenza virus were not significantly different among the three years studied, at 5.3, 6.0 and 6.3% for 2013, 2014 and 2015, respectively.
Discussion and conclusion
The MERS-CoV and respiratory viruses detection results at points of entry in China from 2013 to 2015 indicated that there were no MERS-CoV infection but a 5.7% positive influenza viruses in returning Chinese pilgrims.
As of November 2015, there had been 1618 laboratory-confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection reported to the World Health Organization, and at least 579 cases had died [1, 2]. Most cases of MERS-CoV infection were reported from the Kingdom of Saudi Arabia. Annually, more than 2 million Muslim pilgrims from 184 countries attend the Hajj pilgrimage in Mecca, Saudi Arabia . This mass gathering of pilgrims presents a global health risk due to the potential spread of infectious diseases, and respiratory infections are the most common infections transmitted between Hajj pilgrims [4, 5]. The viruses most commonly isolated from symptomatic patients during the Hajj pilgrimage were influenza virus and coronaviruses [4–7]. There is global concern that travelers returning from pilgrimage could contribute to the international spread of MERS-CoV. The International Health Regulations (IHR) Emergency Committee suggested that all countries perform surveillance for MERS-CoV among pilgrims during and after Hajj . In China, about 11,000 Muslim pilgrims participate in the Hajj gathering in Mecca annually . This is the first report of the molecular screening for MERS-CoV and respiratory viruses among returning pilgrims at points of entry in China, carried out from 2013 to 2015.
The participants in this study were adult Hajj pilgrims who traveled in groups to Mecca, Saudi Arabia, and stayed there for 35–40 days from September to October, 2013–2015. In China, the government arranged charter flights for Hajj pilgrims to visit Mecca. Infectious disease monitoring and surveillance of foreigners travelers coming from other countries is the responsibility of AQSIQ (General Administration Quality Supervision Inspection and Quarantine of the People’s Republic of China). AQSIQ supervises 283 entry–exit ports in China, and operates on behalf of the national government. For all Chinese Hajj pilgrims, personal and flight information was recorded and a medical examination was conducted, including vaccination by a local AQSIQ office, before the trip to Mecca. Xinjiang and Gansu Province have the highest number of Hajj pilgrims visiting Mecca each year. In this study, our institute, the Chinese Academy of Inspection and Quarantine, cooperated with the Xinjiang and Gansu Entry–Exit Inspection and Quarantine Bureau. We randomly selected 847 returning pilgrims arriving at Xinjiang and Gansu airports, and asked for their consent to participate in this study. In China, every entry–exit airport has an infrared radiation thermometer, installed by AQSIQ, to screen travelers’ body temperatures. Among 847 returning pilgrims, 20 returning pilgrims triggered the alarm on passing through the infrared radiation thermometer installed at the airport to monitor travelers’ body temperature. Sixteen of these travelers were confirmed by using a clinical thermometer to have the onset of fever (>37.5 °C), and also reported a sore throat or cough on the returning flight. The remaining 831 returning pilgrims did not have a fever or other symptoms. The numbers of travelers with fever in each year were 7 (2013), 4 (2014), and 5 (2015). The mean age of all participants was 62.24 years old (SD = 6.19). In this study, 351 were females and 496 were males, and they were all Moslem. All pilgrims were asked to undergo a health examination and were vaccinated against influenza A and B in a local travel health center a week prior to departure. All participants included in this study were voluntary and signed consent forms.
For the detection of viral infection, samples included lower respiratory tract sputum, washes, and upper respiratory tract oropharyngeal swab specimens. Lower respiratory tract sputum samples were used to test for respiratory viruses during this 3-year period. All pilgrims were tested for influenza and MERS, but only those with fever were tested for the other viruses. All specimens were collected immediately when returning pilgrims arrived at each point of entry, and nucleic acid was isolated and immediately screened by real time RT-PCR for the upE and ORF1a genes of MERS-CoV provided by the World Health Organization [10, 11]. All real time PCR protocols for influenza A and B followed those used by a previous study . Samples from travelers displaying a fever were also tested by real time RT-PCR for human metapneumo virus (hMPV), human respiratory syncytial virus (hRSV), and human coronaviruses HKU1, 229E, and OC43 . According to the infection control and health quarantine rules at airports, the time taken between specimen collection and the reporting of results was within 4 h.
The rates of respiratory virus detection among Hajj pilgrims returning to China from 2013 to 2015
(χ2 = 44.24, P = 0.00)
(χ2 = 0.37, P = 0.83)
Total positives %
Respiratory syncytial virus
Human coronavirus HKU1
Human coronavirus 229E
Human coronavirus OC43
Middle East respiratory syndrome coronavirus (MERS-CoV)
Total influenza (A and B) %
Total respiratory infection
In this study, we did not detect any cases of MERS-CoV infection but respiratory virus infections including influenza A and B, hMPV, hRSV, and human coronavirus were detected among Hajj pilgrims returning to China. This result was consistent with the outcomes of similar studies of respiratory virus detection in Hajj pilgrims in France, North India, Egypt, Ghana, Saudi Arabia, and the UK [12–17]. Regarding the detection of influenza viruses, these studies reported detection rates of 7.8% in France (no vaccination) , 11% in North India (72% vaccination rate) , 14% in Egypt (20% vaccination rate) , 1.3% in Ghana (vaccination rate unknown) , and 7% in the UK (37% vaccination rate) . In our study, all participants had been vaccinated against influenza virus, but 5.7% tested positive for influenza virus infection. We are unable to measure the direct impact of influenza vaccination on the resistance of Hajj pilgrims to influenza infection and further studies are required to understand the efficacy of the influenza vaccine among this population. However, increasing the rate of vaccination will help protect individuals, particularly those travelers that are most vulnerable to infection such as older adults and those that may be immunocompromised. A combination of vaccination and rapid antiviral treatment of symptomatic individuals currently offer the best strategy for the prevention and treatment of infections among Hajj pilgrims.
In this study, MERS-CoV was not detected in any of the upper respiratory swabs or sputum specimens tested. However, limiting the time taken for sample collection, the type of samples collected and the selection of participants can all affect the rates of positive detection. In previous studies, most samples were nasal swabs collected from strongly suspected symptomatic participants after they were under investigation in hospital [13–17]. However, in our study, swabs were collected from both suspected and asymptomatic returning pilgrims immediately after their arrival at airports. Our sampling design would therefore include some healthy pilgrims, thereby decreasing the rate of detection of respiratory virus infections. In addition, upper respiratory samples (nasopharyngeal swabs and sputum) have been demonstrated to have a lower MERS-CoV genome load than lower respiratory specimens such as tracheal aspirates and bronchoalveolar lavage specimens . This may also have limited the detection of MERS-CoV in our study.
The findings from our study demonstrate the risk of influenza infection among travelers during mass gatherings, and confirming the need for effective surveillance of imported infectious diseases at entry points into China. The Hajj pilgrimage provides a unique opportunity to test the effectiveness of different infectious disease preventive and detective measures that require a large sample size. Continued annual monitoring of MERS-CoV, influenza viruses, and other respiratory viruses (such as human rhinovirus), is needed to increase our understanding of the epidemic patterns of respiratory virus infections among Hajj pilgrims in China.
We wish to thank Dr. Dexin Li for his extensive support and assistance with the study.
This study was supported by the China Mega-Project for Infectious Diseases grants (2013ZX10004–101,006), (2013ZX10004202–001-006), and CAIQ Research Fund (2016JK012).
Availability of data and materials
All data generated or analyzed during this study are included in this published article.
XM and FL carried out sample collection and drafted the manuscript. LL, LZ, and LM extracted RNA and collected clinical samples. AA, LW, WZ, and PY recorded the experimental data and collated the results Tables. KH designed the study, edited the manuscript, and supervised the experiments. All authors read and approved the final manuscript.
Ethics approval and consent to participate
The study was conducted according to the protocol approved by the Human Research Ethics Committee, Chinese Academy of Inspection and Quarantine, in compliance with the provisions for human research in the Helsinki Declaration (ES-0823696/2015/384HQ). Written informed consent was obtained from all participants.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- World Health Organization. Global alert and response (GAR). Middle East respiratory syndrome coronavirus. 2015. http://www.who.int/csr/disease/coronavirus_infections/en/ cited 2015 Mar 10.
- Arabi YM, Balkhy HH, Hayden FG, Bouchama A, Luke T, Baillie JK, Al-Omari A, Hajeer AH, Senga M, Denison MR, Nguyen-Van-Tam JS, Shindo N, Bermingham A, Chappell JD, Van Kerkhove MD, Fowler RA. Middle East respiratory syndrome. N Engl J Med. 2017;376:584–94.View ArticlePubMedPubMed CentralGoogle Scholar
- Zumla A, Hui D, Perlman S. Middle East respiratory syndrome. Lancet. 2015;386:995–1007.View ArticlePubMedPubMed CentralGoogle Scholar
- Gautret P, Benkouiten S, Al-Tawfiq JA, Memish ZA. Hajj-associated viral respiratory infections: a systematic review. Travel Med Infect Dis. 2016;14:92–109.View ArticlePubMedGoogle Scholar
- Annan A, Owusu M, Marfo KS, Larbi R, Sarpong FN, Adu-Sarkodie Y, Amankwa J, Fiafemetsi S, Drosten C, Owusu-Dabo E, Eckerle I. High prevalence of common respiratory viruses and no evidence of Middle East respiratory syndrome coronavirus in Hajj pilgrims returning to Ghana, 2013. Tropical Med Int Health. 2015;20:807–12.View ArticleGoogle Scholar
- Haworth E, Barasheed O, Memish ZA, Rashid H, Booy R. Prevention of influenza at Hajj: applications for mass gatherings. J R Soc Med. 2013;106:215–23.View ArticlePubMedPubMed CentralGoogle Scholar
- Alfaraj SH, Al-Tawfiq JA, Alzahrani NA, Altwaijri TA, Memish ZA. The impact of co-infection of influenza a virus on the severity of Middle East respiratory syndrome Coronavirus. J Inf Secur. 2017;S0163-4453:30048.Google Scholar
- World Health Organization Statement on the tenth meeting of the IHR Emergency committee concerning MERS-CoV. 2015. http://www.who.int/mediacentre/news/statements/2015/ihr-emergency-committee-mers/en/. cited 2015 Sep 3.
- Guan WD, Mok CKP, Chen ZL, Feng LQ, Li ZT, Huang JC. Characteristics of traveler with Middle East respiratory syndrome, China, 2015. Emerg Infect Dis. 2015;21:12.Google Scholar
- Corman VM, Müller MA, Costabel U, Timm J, Binger T, Meyer B. Assays for laboratory confirmation of noval human coronavirus (hCoV-EMC) infection. Euro Surveill. 2012;17(49):20334.View ArticlePubMedGoogle Scholar
- Corman VM, Eckerle I, Bleicker T, Zaki A, Landt O, Eschbach-Bludau M. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill. 2012;17(39):20285.View ArticlePubMedGoogle Scholar
- Amer HM, Alshaman MS, Farrag MA, Hamad ME, Alsaadi MM, Almajhdi FN. Epidemiology of 11 respiratory RNA viruses in a cohort of hospitalized children in Riyadh, Saudi Arabia. J Med Virol. 2016;88:1086–91.View ArticlePubMedGoogle Scholar
- Refaey S, Amin MM, Roguski K, Azziz-Baumgartner E, Uyeki TM, Labib M, Kandeel A. Cross-sectional survey and surveillance for influenza viruses and MERS-CoV among Egyptian pilgrims returning from Hajj during 2012-2015. Influenza Other Respir Viruses. 2017;11:57–60.View ArticlePubMedGoogle Scholar
- Koul PA, Mir H, Saha S, Chadha MS, Potdar V, Widdowson MA, Lal RB, Krishnan A. Influenza not MERS CoV among returning Hajj and Umrah pilgrims with respiratory illness, Kashmir, north India, 2014-15. Travel Med Infect Dis. 2016;S1477-8939:30208–3.Google Scholar
- Gautret P, Charrel R, Belhouchat K, Drali T, Benkouiten S, Nougairede A, Zandotti C, Memish ZA, al Masri M, Gaillard C, Brouqui P, Parola P. Lack of nasal carriage of novel corona virus (HCoV-EMC) in French Hajj pilgrims returning from the Hajj 2012, despite a high rate of respiratory symptoms. Clin Microbiol Infect. 2013;19:E315–7.View ArticlePubMedGoogle Scholar
- Gautret P, Charrel R, Benkouiten S, Belhouchat K, Nougairede A, Drali T. Lack of MERS Coronavirus but prevalence of influenza virus in French pilgrims after 2013 Hajj. Emerg Infect Dis. 2014;20(4):728–30.View ArticlePubMedPubMed CentralGoogle Scholar
- Rashid H, Shafi S, Haworth E, Bashir HE, Memish ZA, Sudhanva M, Smith MH, Auburn H, Booy R. Viral respiratory infections at the Hajj: comparison between UK and Saudi pilgrims. Clin Microbiol Infect. 2008;14(6):569–74.View ArticlePubMedGoogle Scholar
- Memish ZA, Al-Tawfiq JA, Makhdoom HQ, Assiri A, Alhakeem RF, Albarrak A, Alsubaie S, Al-Rabeeah AA, Hajomar WH, Hussain R, Kheyami AM, Almutairi A, Azhar EI, Drosten C, Watson SJ, Kellam P, Cotten M, Zumla A. Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome. J Infect Dis. 2014;210:1590–4.View ArticlePubMedGoogle Scholar